Description

Empowering Biotech & Medtech Success—Consulting Services

What I Offer

Go-to-Market Strategy: Craft and execute actionable market entry blueprints that put patient impact first—ensuring rapid adoption and measurable outcomes.

Launch Planning: Orchestrate seamless, cross-functional launches so your products and services enter the market with maximum momentum.
Collaboration & Alliance Management: Build and manage strategic partnerships. Leverage my extensive network to open doors, scale reach, and generate win-win outcomes.

Startup Coaching & Fundraising Prep: Mentor startups from concept to investor-ready. I focus on team building, validating business models, and sharpening your story for fundraising.
Commercial & Market Analysis: Deliver incisive market, competitor, and financial insights to inform your strategy and maximize your unique value.

Business Development Roadmaps: Identify high-potential growth opportunities and develop step-by-step plans for lasting business expansion.
Funding & VC Access: Connect you with the right investors and VCs, preparing your pitch and materials for a successful raise.

Why Work With Me?

As a consultant, I bring a unique blend of insight, industry expertise, and a proven commitment to advancing patient-centered healthcare. Whether you’re scaling a startup, launching a new product, or seeking strategic partnerships, I provide hands-on support tailored to your goals.

Ready to drive transformative impact in biotech and medtech?

Let’s connect and explore how I can help you succeed—starting with purpose and patient value.

Industry field of expertise

Languages

German
Native or bilingual
English
Native or bilingual
Hungarian
Native or bilingual
Dutch
Basic

Workplace preferences

Can work on-site

Brussels (up to 50km)

Freelance
Management Consultant
May 2025 - Today (1 year and 1 month)
Brussels, Belgium
Advised CEOs and boards of biomedical / med-tech / health innovation companies on commercial strategy, business development, and go-to-market (GTM) plans to accelerate commercialization and clinical translation.
Built investor-ready narratives and operating plans to support fundraising(including Series A readiness), partnering strategy, and prioritization of programs and markets (Global scope).
Led due diligence: diagnostic of commercial and operating issues, scenario planning, resource reallocation, and performance management to restore execution discipline and growth trajectory. (VC and PE driven).
Structured and facilitated board-level decisions: clarified strategic options,risks, and trade-offs; aligned stakeholders; translated strategy into measurable milestones, KPIs, and execution roadmaps.
Developed partnership pipelines (strategic partners, clinical sites, KOLs, and ecosystem stakeholders) to expand network reach and unlock new routes to market.
Commercial strategy biotech fund raising venture funding
UCB
Chief of Staff Europe - Rare Disease Organization
August 2022 - January 2025 (2 years and 5 months)
Brussels, Belgium

- Cross-functional launch preparation across Europe for 3 rare disease assets (2 in gMG and Tk2D).
- Being the right hand to the EU business unit head (strategic planning, financial and FTE planning and management, team management, early access program, supply chain, access, and medical integration).
UCB
Health Tech - Seizure Detection Device Lead
April 2017 - August 2022 (5 years and 4 months)
Brussels, Belgium

- Lead a consortium (40+ people) that took an idea to create a seizure detection device and made it to the market(CE/510k) after we validated with 500+ patients in a clinical study.
- Byteflies is commercializing the device.
- Managed 5 Mio Euro Non-dilutive funding (Icon/IMEC & EIT Health).
- Alliance and partnership management: 5+ years, 3 startups, 7 universities, pharma.